Christensen Bret 4

What Happened

• Bret Christensen, a director of biote Corp (BTMD), was granted a derivative award of 130,000 shares on 2026-06-08. The award is reported at a grant price of $0.00, so no cash was exchanged at grant. This is an equity award (not a sale or open-market purchase).

Key Details

• Transaction date: 2026-06-08; Form 4 filed: 2026-06-10 (within the typical 2-business-day reporting window).
• Award: 130,000 shares; reported price: $0.00 (derivative instrument).
• Shares owned after transaction: not disclosed in the provided filing.
• Footnote: All shares subject to the award vest on the earlier of June 8, 2027 or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, subject to Christensen’s continuous service through such vesting date.
• Transaction code: A (grant/award).

Context

• This filing reports an award/grant rather than a purchase or sale; such grants are commonly part of director compensation and vest over time. Because the award is reported as a derivative at $0, the filing does not indicate immediate cash value realization. The vesting condition means the shares will only become controllable ownership if Christensen remains in service until the stated vesting date(s).